Aashna Sinha
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Aashna Sinha has a total of 38 co-authors. Here are the top co-authors by number of shared publications:
- Hanumanthayya Malathi
JAIN (Deemed-to-be University), Department of Biotechnology and Genetics, Bangalore, Karnataka, India
3 shared publications - Aniruddh Dash
Department of Orthopaedics, IMS and SUM Hospital, Siksha ’O’ Anusandhan, Bhubaneswar, India
2 shared publications Anita Gehlot
Uttaranchal University
2 shared publications- Aseel Smerat
Faculty of Educational Sciences, Al-Ahliyya Amman University, Amman 19328, Jordan
2 shared publications Fraiz Parveen
Uttaranchal University
2 shared publicationsGeetanjali Shukla
Uttaranchal University
2 shared publications
Latest Publications
- 28 July 2026
- Published by Taylor & Francis in Immunotherapy
- p. 1-18
Green synthesis nanoparticles for cancer immunotherapy: current applications and future perspectives
1. Cancer remains one of the greatest challenges in modern medicine because of tumor heterogeneity, immune evasion, and resistance to standard-of-care therapies, which limit the achievement of dura...
- 28 July 2026
- Published by Taylor & Francis in Immunotherapy
- p. 1-18
Green synthesis nanoparticles for cancer immunotherapy: current applications and future perspectives
1. Cancer remains one of the greatest challenges in modern medicine because of tumor heterogeneity, immune evasion, and resistance to standard-of-care therapies, which limit the achievement of dura...
- 9 July 2026
- Published by Springer Nature in Cancer Chemotherapy and Pharmacology
- Vol. 96 (1) , 73
Anti-PD-1 single-chain variable fragments in cancer immunotherapy: from molecular engineering to clinical translation
The programmed death-1 (PD-1) immune checkpoint is a core regulator of T-cell exhaustion and immune evasion in cancer. While PD-1/PD-L1 monoclonal antibodies have changed the landscape of cancer immunotherapy, there are barriers to broader application due to their large size, potential for systemic toxicities, and high production costs. In this review article, we will focus on therapeutic development, functional applications, and translational advances of anti-PD-1 single-chain variable fragments (scFvs). Advances in phage-display libraries, immunization methods, and antibody engineering have helped develop high-affinity scFvs with novel structural and mechanistic properties. Direct functional applications incorporating anti-PD-1 scFvs are bispecific and trispecific constructs, antibody–drug conjugates (ADCs), immunotoxins, nanoparticles, and biological vector carriers that incorporate checkpoint blockade with targeted cytotoxicity or immunostimulation. Engineered immune cells, such as armored CAR-Ts, NK cells, and MSCs, can secrete or display anti-PD-1 scFvs within the tumor to provide localized checkpoint inhibition, enhance effector-cell persistence, and remodel the tumor microenvironment. Oncolytic and non-replicating viral vectors can further confine scFv activity to tumors, coupling checkpoint blockade with oncolysis, cytokine expression, or bispecific T-cell engagers. Early-phase clinical trials are currently studying TILs and CAR-TILs engineered to secrete scFvs and oncolytic HSV-1 encoding multifunctional checkpoint payloads across a variety of solid tumors. Taken together, anti-PD-1 scFvs represent a modular platform for localized checkpoint inhibition and potentially improved cost-effectiveness compared with systemic antibodies. Future work should prioritize rational combination strategies and well-designed clinical trials that integrate anti-PD-1 scFv platforms with other immunotherapies and standard treatments to maximize clinical benefit. Graphical abstract
- 9 July 2026
- Published by Springer Nature in Cancer Chemotherapy and Pharmacology
- Vol. 96 (1) , 73
Anti-PD-1 single-chain variable fragments in cancer immunotherapy: from molecular engineering to clinical translation
The programmed death-1 (PD-1) immune checkpoint is a core regulator of T-cell exhaustion and immune evasion in cancer. While PD-1/PD-L1 monoclonal antibodies have changed the landscape of cancer immunotherapy, there are barriers to broader application due to their large size, potential for systemic toxicities, and high production costs. In this review article, we will focus on therapeutic development, functional applications, and translational advances of anti-PD-1 single-chain variable fragments (scFvs). Advances in phage-display libraries, immunization methods, and antibody engineering have helped develop high-affinity scFvs with novel structural and mechanistic properties. Direct functional applications incorporating anti-PD-1 scFvs are bispecific and trispecific constructs, antibody–drug conjugates (ADCs), immunotoxins, nanoparticles, and biological vector carriers that incorporate checkpoint blockade with targeted cytotoxicity or immunostimulation. Engineered immune cells, such as armored CAR-Ts, NK cells, and MSCs, can secrete or display anti-PD-1 scFvs within the tumor to provide localized checkpoint inhibition, enhance effector-cell persistence, and remodel the tumor microenvironment. Oncolytic and non-replicating viral vectors can further confine scFv activity to tumors, coupling checkpoint blockade with oncolysis, cytokine expression, or bispecific T-cell engagers. Early-phase clinical trials are currently studying TILs and CAR-TILs engineered to secrete scFvs and oncolytic HSV-1 encoding multifunctional checkpoint payloads across a variety of solid tumors. Taken together, anti-PD-1 scFvs represent a modular platform for localized checkpoint inhibition and potentially improved cost-effectiveness compared with systemic antibodies. Future work should prioritize rational combination strategies and well-designed clinical trials that integrate anti-PD-1 scFv platforms with other immunotherapies and standard treatments to maximize clinical benefit. Graphical abstract
- Open Access
- 3 July 2026
- Published by Asian Publication Corporation in Asian Journal of Chemistry
- Vol. 38 (7) , 1953-1959
Comparative Phytochemical Screening by GC-MS and Assessment of Biological Activities of Leaves, Stem and Root of Costus igneus
Costus igneus (insulin plant), is among the important medicinal plant known for its diverse medicinal properties; in particular, to manage blood glucose levels. The present study is a comparative analysis of phytochemical composition and pharmacological activities of leaves, stem and root of insulin plant through FTIR, GC-MS analysis, DPPH radical scavenging ability, protein denaturation inhibition and in vitro α-amylase inhibitory activity. The present study aimed to evaluate the antioxidant and anti-inflammatory potential of different plant parts. Among the extracts tested, the leaf extract exhibited the highest α-amylase inhibitory activity, showing efficacy comparable to that of the standard drug acarbose. The leaf extract exhibited the highest DPPH radical scavenging activity, reaching maximum inhibition at 100 µg/mL. In the protein denaturation assay, the stem extract showed anti-inflammatory activity comparable to salicylic acid and second only to the leaf extract. Phytochemical analysis revealed the presence of diverse bioactive compounds in all plant parts, with the root containing the highest concentration and greatest phytochemical diversity. While previous studies have largely focused on the leaves, the present findings demonstrate that the stem and root also possess considerable therapeutic potential, expanding their prospects for healthcare and related industrial applications.
- 3 July 2026
- Published by Asian Publication Corporation in Asian Journal of Chemistry
- Vol. 38 (7) , 1953-1959
Open AccessComparative Phytochemical Screening by GC-MS and Assessment of Biological Activities of Leaves, Stem and Root of Costus igneus
Costus igneus (insulin plant), is among the important medicinal plant known for its diverse medicinal properties; in particular, to manage blood glucose levels. The present study is a comparative analysis of phytochemical composition and pharmacological activities of leaves, stem and root of insulin plant through FTIR, GC-MS analysis, DPPH radical scavenging ability, protein denaturation inhibition and in vitro α-amylase inhibitory activity. The present study aimed to evaluate the antioxidant and anti-inflammatory potential of different plant parts. Among the extracts tested, the leaf extract exhibited the highest α-amylase inhibitory activity, showing efficacy comparable to that of the standard drug acarbose. The leaf extract exhibited the highest DPPH radical scavenging activity, reaching maximum inhibition at 100 µg/mL. In the protein denaturation assay, the stem extract showed anti-inflammatory activity comparable to salicylic acid and second only to the leaf extract. Phytochemical analysis revealed the presence of diverse bioactive compounds in all plant parts, with the root containing the highest concentration and greatest phytochemical diversity. While previous studies have largely focused on the leaves, the present findings demonstrate that the stem and root also possess considerable therapeutic potential, expanding their prospects for healthcare and related industrial applications.
- 23 June 2026
- Published by Taylor & Francis
- p. 353-368
Bio-Inspired Water Purification
Water pollution and sewage are very pressing global challenges that must be resolved by sustainable or innovative measures. Conventional water purification processes tend to be energy-intensive and involve chemical treatments, which, in turn, pose environmental problems. These materials offer an environment-friendly and efficient solution by looking into filtering, absorbing, and self-cleaning mechanisms within nature. A host of bio-inspired materials are discussed in the chapter, such as aquaporin-based membranes for enhanced water filtration, superhydrophobic surfaces inspired by the lotus leaf for antifouling in filtration stability, and photocatalytic nanomaterials for degrading organic pollutants. Such biomimetic strategies are also helpful in the removal of contaminants while preserving the environment. The chapter goes on to examine bio-inspired water purification processes and their applications in wastewater treatment, desalination, and drinking water purification with respect to one Sustainable Development Goal, namely SDG 6 (Clean Water and Sanitation). Limitations remain concerning scale of implementation, cost feasibility, and technology, though they show promise. Future directions involve incorporating artificial intelligence, nanotechnology, and hybrid biomimetic systems for enhancing efficiency and scalability. With a focus on nature’s design principles, bio-inspired water treatment technologies embody a sustainable pathway to cleaner water and a healthy environment directly linked to global water security and climate resilience.
- 23 June 2026
- Published by Taylor & Francis
- p. 353-368
Bio-Inspired Water Purification
Water pollution and sewage are very pressing global challenges that must be resolved by sustainable or innovative measures. Conventional water purification processes tend to be energy-intensive and involve chemical treatments, which, in turn, pose environmental problems. These materials offer an environment-friendly and efficient solution by looking into filtering, absorbing, and self-cleaning mechanisms within nature. A host of bio-inspired materials are discussed in the chapter, such as aquaporin-based membranes for enhanced water filtration, superhydrophobic surfaces inspired by the lotus leaf for antifouling in filtration stability, and photocatalytic nanomaterials for degrading organic pollutants. Such biomimetic strategies are also helpful in the removal of contaminants while preserving the environment. The chapter goes on to examine bio-inspired water purification processes and their applications in wastewater treatment, desalination, and drinking water purification with respect to one Sustainable Development Goal, namely SDG 6 (Clean Water and Sanitation). Limitations remain concerning scale of implementation, cost feasibility, and technology, though they show promise. Future directions involve incorporating artificial intelligence, nanotechnology, and hybrid biomimetic systems for enhancing efficiency and scalability. With a focus on nature’s design principles, bio-inspired water treatment technologies embody a sustainable pathway to cleaner water and a healthy environment directly linked to global water security and climate resilience.
- 8 May 2026
- Published by World Scientific Pub Co Pte Ltd in Modern Physics Letters B
- Vol. 40 (17)
Plasmonic SPR sensor using SiO 2 /Ag-Au alloy/Cu/LaF/Graphene novel Kretschmann structure for SARS-CoV-2 detection: A theoretical study
A surface plasmon resonance (SPR) plasmonic sensor design is numerically investigated using the angle interrogation method for the detection of SARS-CoV-2 using a heterogeneous layered architecture consisting of Silicon dioxide (SiO 2 ) prism/Ag-Au Alloy (AAA)/Copper/Lanthanum fluoride (LaF)/Graphene stack in Kretschmann geometry. The combination of SiO 2 with Ag-Au alloy/Cu bilayer supports surface plasmon excitation with minimal reflectance. Also, LaF interlayer and Graphene nanosheet work together to enhance optical impedance matching and field confinement at the sensing interface, further increasing the performance of the proposed sensor. This proposed study is based on the transfer matrix method to evaluate the reflectivity and relates the shift in the resonance angle to variation in refractive index (RI) caused by an increase in concentration (0–1000[ ]nM) of SARS-CoV-2 virus surface coverage, thus enabling the inference of virus concentration from the observed angular response. The proposed sensor design attains the highest sensitivity of 386.666 deg/RIU with FoM of 52.98 RIU[ ].
- 8 May 2026
- Published by World Scientific Pub Co Pte Ltd in Modern Physics Letters B
- Vol. 40 (17)
Plasmonic SPR sensor using SiO 2 /Ag-Au alloy/Cu/LaF/Graphene novel Kretschmann structure for SARS-CoV-2 detection: A theoretical study
A surface plasmon resonance (SPR) plasmonic sensor design is numerically investigated using the angle interrogation method for the detection of SARS-CoV-2 using a heterogeneous layered architecture consisting of Silicon dioxide (SiO 2 ) prism/Ag-Au Alloy (AAA)/Copper/Lanthanum fluoride (LaF)/Graphene stack in Kretschmann geometry. The combination of SiO 2 with Ag-Au alloy/Cu bilayer supports surface plasmon excitation with minimal reflectance. Also, LaF interlayer and Graphene nanosheet work together to enhance optical impedance matching and field confinement at the sensing interface, further increasing the performance of the proposed sensor. This proposed study is based on the transfer matrix method to evaluate the reflectivity and relates the shift in the resonance angle to variation in refractive index (RI) caused by an increase in concentration (0–1000[ ]nM) of SARS-CoV-2 virus surface coverage, thus enabling the inference of virus concentration from the observed angular response. The proposed sensor design attains the highest sensitivity of 386.666 deg/RIU with FoM of 52.98 RIU[ ].
- Open Access
- 29 April 2026
- Published by International Consortium of Academic Professionals for Scientific Research
- p. 01-87
Blue Algorithms: AI in Aquatic Systems
Blue Algorithms: AI in Aquatic Systems is a broad and perspective-looking study on water bodies as dynamic and adaptive natural systems that are complex interactions of physical, chemical, biological, and anthropogenic processes. Going beyond the traditional hydrological views, the book places rivers, lakes, oceans, wetlands, and groundwater systems in the role of constantly evolving entities with self-regulating characteristics and feedback-based responses, and resiliency to environmental factors. The book applies artificial intelligence and hydrology, aquatic ecology, geospatial science, and environmental engineering to reveal how data-driven and hybrid AI models are changing the ways in which the spatial and temporal aspects of aquatic systems are observed, interpreted, and managed. The book focuses on mechanistic knowledge and predictive intelligence and how machine learning, digital twins, and sophisticated sensing technologies can be used to provide better insights about processes, early warning signs, and adaptive decision-making. Governance, ethics and data stewardship are also accorded equal attention, which considers the impacts of digital water infrastructures on the societies. In general, the book presents a scientifically sound system of resilience, clarity and future readiness of water management in the era of climate change, urbanization, and global environmental transformation.
- 29 April 2026
- Published by International Consortium of Academic Professionals for Scientific Research
- p. 01-87
Open AccessBlue Algorithms: AI in Aquatic Systems
Blue Algorithms: AI in Aquatic Systems is a broad and perspective-looking study on water bodies as dynamic and adaptive natural systems that are complex interactions of physical, chemical, biological, and anthropogenic processes. Going beyond the traditional hydrological views, the book places rivers, lakes, oceans, wetlands, and groundwater systems in the role of constantly evolving entities with self-regulating characteristics and feedback-based responses, and resiliency to environmental factors. The book applies artificial intelligence and hydrology, aquatic ecology, geospatial science, and environmental engineering to reveal how data-driven and hybrid AI models are changing the ways in which the spatial and temporal aspects of aquatic systems are observed, interpreted, and managed. The book focuses on mechanistic knowledge and predictive intelligence and how machine learning, digital twins, and sophisticated sensing technologies can be used to provide better insights about processes, early warning signs, and adaptive decision-making. Governance, ethics and data stewardship are also accorded equal attention, which considers the impacts of digital water infrastructures on the societies. In general, the book presents a scientifically sound system of resilience, clarity and future readiness of water management in the era of climate change, urbanization, and global environmental transformation.
- Open Access
- 10 March 2026
- Published by The ScienceIn Publishing in Journal of Integrated Science and Technology
- Vol. 14 (4) , 1557
Medicinal applications of Costus speciosus and Costus igneus: An analysis for health benefits
Lifestyle diseases, chronic diseases and diabetes have thrown other challenges in the modern-day’s global health landscape, presenting hitherto unprecedented challenges to the public health systems worldwide. According to the World Health Organization (WHO), cardiovascular illness accounts for nearly 17.9 million deaths annually, followed by cancers (9.3 million), chronic respiratory diseases (4.1 million) and diabetes (2.0 million including kidney disease caused by diabetes). The high level of dependency on synthetic drugs to manage these diseases worsens the health effects of various ailments to heart diseases, diabetes and others. The treatment of diabetes requires certain synthetically produced insulin and oral hypoglycaemic, which have various side effects, and their efficacy is not generalized. Further, the discovery of antibiotic resistance is a major threat to the world’s health as most synthetic antibiotics are normally becoming ineffective against the resistant bacterial strains, thus raising failure and mortality rates from infections that antibiotics supposedly controlled. Of course, the application of these pharmacological treatments has been critical in various ailment and life span. Nonetheless, the continued use of these therapies has additional side effects including toxicity, drug resistance and other iatrogenic factors. The increase in the understanding of other health issues that are present across the globe especially the so-called lifestyle diseases like diabetes, has brought about interest in natural remedies including the use of plants as used in traditional medical systems. Two such species can be helped to address these problems, namely Costus speciosus and Costus igneus. These plants have been used in the tribal, ayurveda and some other terrella medicine systems as they proved to contain features that have therapeutic values. Crepe ginger scientifically known as Costus speciosus, has active ingredients that include diosgenin and saponins that might play a crucial role in controlling blood sugar, possess anti-inflammation and antioxidant properties. Similarly, Costus igneus is usually referred to as insulin plant owing to the fact that, it can decrease blood sugar levels can act as a natural cure to the undesirable condition of diabetes. Various health benefits and pharmacological properties of these plants is highlighted in the current review. This review would also help to alleviate the crisis of synthetic medicines, promote the meaningful use of natural medicaments, and enhance the global health condition.
- 10 March 2026
- Published by The ScienceIn Publishing in Journal of Integrated Science and Technology
- Vol. 14 (4) , 1557
Open AccessMedicinal applications of Costus speciosus and Costus igneus: An analysis for health benefits
Lifestyle diseases, chronic diseases and diabetes have thrown other challenges in the modern-day’s global health landscape, presenting hitherto unprecedented challenges to the public health systems worldwide. According to the World Health Organization (WHO), cardiovascular illness accounts for nearly 17.9 million deaths annually, followed by cancers (9.3 million), chronic respiratory diseases (4.1 million) and diabetes (2.0 million including kidney disease caused by diabetes). The high level of dependency on synthetic drugs to manage these diseases worsens the health effects of various ailments to heart diseases, diabetes and others. The treatment of diabetes requires certain synthetically produced insulin and oral hypoglycaemic, which have various side effects, and their efficacy is not generalized. Further, the discovery of antibiotic resistance is a major threat to the world’s health as most synthetic antibiotics are normally becoming ineffective against the resistant bacterial strains, thus raising failure and mortality rates from infections that antibiotics supposedly controlled. Of course, the application of these pharmacological treatments has been critical in various ailment and life span. Nonetheless, the continued use of these therapies has additional side effects including toxicity, drug resistance and other iatrogenic factors. The increase in the understanding of other health issues that are present across the globe especially the so-called lifestyle diseases like diabetes, has brought about interest in natural remedies including the use of plants as used in traditional medical systems. Two such species can be helped to address these problems, namely Costus speciosus and Costus igneus. These plants have been used in the tribal, ayurveda and some other terrella medicine systems as they proved to contain features that have therapeutic values. Crepe ginger scientifically known as Costus speciosus, has active ingredients that include diosgenin and saponins that might play a crucial role in controlling blood sugar, possess anti-inflammation and antioxidant properties. Similarly, Costus igneus is usually referred to as insulin plant owing to the fact that, it can decrease blood sugar levels can act as a natural cure to the undesirable condition of diabetes. Various health benefits and pharmacological properties of these plants is highlighted in the current review. This review would also help to alleviate the crisis of synthetic medicines, promote the meaningful use of natural medicaments, and enhance the global health condition.
- 12 November 2025
- Published by International Consortium of Academic Professionals for Scientific Research
Next-Gen Biotech: AI-Driven Innovations
In an era marked by rapid technological evolution, biotechnology stands at the forefront of scientific innovation, reshaping the very fabric of life itself. Next-Gen Biotech: AI-Driven Innovations explores the profound synergy between artificial intelligence (AI) and biotechnology, a fusion that is unlocking unprecedented possibilities across healthcare, agriculture, environmental sustainability, and beyond. AI is no longer a tool of the future it is the catalyst of today's breakthroughs, driving precision, accelerating discovery, and revolutionizing how we understand and engineer living systems. This book delves into how AI models predict genetic modifications, optimize drug discovery, enhance bio-manufacturing, and enable next-generation personalized therapies. It highlights real-world case studies, visionary research, and the ethical dimensions that must accompany such transformative progress. With every chapter, readers will witness how the intelligent integration of AI with biotechnology is solving humanity’s most complex challenges from combating pandemics to addressing food security and climate change. Designed for researchers, students, industry professionals, and curious minds, this book offers a roadmap to a future where biology and machine intelligence converge to create a smarter, healthier, and more sustainable world.
- 12 November 2025
- Published by International Consortium of Academic Professionals for Scientific Research
Next-Gen Biotech: AI-Driven Innovations
In an era marked by rapid technological evolution, biotechnology stands at the forefront of scientific innovation, reshaping the very fabric of life itself. Next-Gen Biotech: AI-Driven Innovations explores the profound synergy between artificial intelligence (AI) and biotechnology, a fusion that is unlocking unprecedented possibilities across healthcare, agriculture, environmental sustainability, and beyond. AI is no longer a tool of the future it is the catalyst of today's breakthroughs, driving precision, accelerating discovery, and revolutionizing how we understand and engineer living systems. This book delves into how AI models predict genetic modifications, optimize drug discovery, enhance bio-manufacturing, and enable next-generation personalized therapies. It highlights real-world case studies, visionary research, and the ethical dimensions that must accompany such transformative progress. With every chapter, readers will witness how the intelligent integration of AI with biotechnology is solving humanity’s most complex challenges from combating pandemics to addressing food security and climate change. Designed for researchers, students, industry professionals, and curious minds, this book offers a roadmap to a future where biology and machine intelligence converge to create a smarter, healthier, and more sustainable world.
- Open Access
- 10 May 2025
- Published by International Consortium of Academic Professionals for Scientific Research
- p. 01-94
AI for Humanity: Battling Pandemics with Digital Intelligence
AI for Humanity: Battling Pandemics with Digital Intelligence embarks on a journey across the timeline of some of history's most devastating outbreaks, reformulated by the transformational power of artificial intelligence. Each calamitous event, from the Black Death to a near digital awakening during SARS, from insights via social media frameworks like H1N1 to the stress test of COVID-19, inculcates historical lessons with the technology's current opportunity. Coming across zoonotic threats and antimicrobial resistance, the book shows how having AI has practically become humankind's greatest partner in attempting to predict, check, and most importantly, stop future pandemics even before they begin.
- 10 May 2025
- Published by International Consortium of Academic Professionals for Scientific Research
- p. 01-94
Open AccessAI for Humanity: Battling Pandemics with Digital Intelligence
AI for Humanity: Battling Pandemics with Digital Intelligence embarks on a journey across the timeline of some of history's most devastating outbreaks, reformulated by the transformational power of artificial intelligence. Each calamitous event, from the Black Death to a near digital awakening during SARS, from insights via social media frameworks like H1N1 to the stress test of COVID-19, inculcates historical lessons with the technology's current opportunity. Coming across zoonotic threats and antimicrobial resistance, the book shows how having AI has practically become humankind's greatest partner in attempting to predict, check, and most importantly, stop future pandemics even before they begin.